High Content Screening Market

High Content Screening (HCS) Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025

Owing to enhanced toxicity studies, demand for novel technologies in cell analysis is increasing rapidly across the globe. Instruments with enhanced cell imaging and analysis are preferred for early as well as later stages of the drug discovery process. This is expected to fuel the demand for High Content Screening (HCS) instruments in the near future. Also, increasing government support for life sciences research and increasing progress towards establishment of innovation and research-based biotechnology industries, primarily in countries such as China and India, is expected to contribute towards increased growth rate during the forecast period.

Cell Analysis Instrumentation Market Value Forecast

The global cell analysis instrumentation market is estimated to account for US$ 1,174.1 Mn by 2015 end and is expected to reach US$ 2,120.5 Mn by 2025 at a CAGR of 6.1% during the forecast period.

HIGH CONTENT SCREENING (HCS) Market Value and Volume Forecast

In terms of revenue, the global High Content Screening (HCS) market is currently witnessing major contribution from mid-end and high-end instruments. In addition, research and development on software is likely to fuel market growth during the forecast period. Also, High Content Screening (HCS) installation globally is expected to reach 988 units by the end of 2025, registering a CAGR of 6.6% from 2015 to 2025.

Product Analysis

On the basis of product, High Content Screening (HCS) market segmentation includes cell imaging and analysis equipment, consumables, software and services. Cell imaging and analysis equipment is further segmented as High Content Screening (HCS) instruments, flow cytometers. Also, High Content Screening (HCS) instruments are sub-segmented into high-end High Content Screening (HCS) instruments, mid-end High Content Screening (HCS) instruments and low-end High Content Screening (HCS) instruments. The consumables segment is further sub-segmented as reagents and assay kits, Microplates and other consumables. Among the various segments, software is expected to record highest CAGR of 6.6% during the forecast period. In addition, cell imaging and analysis equipment segment is expected to dominate the market, accounting for 38.4% of the total market.

Key Trends

There has been an increased focus on secondary screening of cells in recent years. This is due to growing concerns of companies for toxicity studies across the globe. Furthermore, risk assessment of critical diseases is gaining importance for drug discovery across pharmaceutical and biotechnology companies. Thus, development of solutions, which offer high sensitivity in detecting problems as critical as hepatoxicity is expected to drive the demand for High Content Screening (HCS) instruments. Although, prices of High Content Screening (HCS) instruments are higher as compared to flow cytometers, availability of these instruments across educational institutions is expected to increase during the forecast period. In order to offer comprehensive offerings to lab services, manufactures need to develop such instruments. Also, there has been an increase in development of automated systems to analyse cell separation and scalability. Demand for efficient purification protocols for therapeutic cells is expected to fuel demand for high-end screening system in the next five to six years.

By Application Analysis

The High Content Screening (HCS) instruments are used for applications, such as primary and secondary screening, toxicity studies, compound profiling, target identification and validation and others. Among all these segments, toxicity studies is expected to record highest CAGR of 7.1% during the forecast period. Primary and secondary screening, and target identification and validation segments collectively are expected to account for around 63.2% of the total High Content Screening (HCS) market by 2025.

High Content Screening Market

By Industry Analysis

The High Content Screening (HCS) instruments are being widely used by end-use sectors, such as pharmaceutical and healthcare, educational institutions, independent contract research organisations, government organisations, biotechnology companies and others. Among all these segments pharmaceutical and healthcare segments is expected to dominate the market in terms of revenue share contribution, registering a CAGR of 6.0% during the forecast period. Biotechnology companies are expected to witness increased installation of high content screening instruments, thus registering highest CAGR of 7.0% during the forecast period.

Asia Pacific Excluding Japan Most Lucrative Market for High Content Screening (HCS) Market

Geographically, the global High Content Screening (HCS) market analysis focusses on North America, Latin America, Eastern Europe, Western Europe, Japan, Asia Pacific Excluding Japan (APEJ), Japan and Middle East and Africa (MEA). In terms of market share contribution, North America represents the most lucrative market, followed by Western Europe and APEJ. North America is expected to register a CAGR of 6.0% accounting for US$ 673.5 million by 2025. In Asia Pacific, China and India owe a significant contribution to growth of Asia Pacific High Content Screening (HCS) market and thus, represent opportunities for manufacturers in the near future. APEJ is expected to record highest CAGR of 7.0% during the forecast period. Japan records comparatively less growth. This is due to high entry barriers for international players to enter the Japan High Content Screening (HCS) market.

Competitive Players Outlook

Since the market for High Content Screening (HCS) instruments is consolidated in nature, major players across the globe are focussed on developing new product offerings across various products, which includes instruments, consumables, software and services for cell analysis. This ensures sustainability in the long run and restricts new entrants from entering the market. The global High Content Screening (HCS) market competitive landscape includes Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., GE Healthcare, Olympus Corporation, PerkinElmer Inc., Merck Millipore Corporation, Danaher Corporation (Molecular Devices), Yokogawa Electric Corporation, Sysmex Corporation and Thorlabs Inc.

This Future Market Insights report examines the ‘High Content Screening (HCS)’ market for the period 2015–2025. New product launches are resulting in product assortment and thus, increased installation of High Content Screening (HCS) instruments. This is expected to bolster growth of the High Content Screening (HCS) market over the next five to six years. Furthermore, increasing government support for research and development for drug discovery processes across the globe is expected to drive the growth of High Content Screening (HCS) market during the forecast period. Companies are focussing on penetrating untapped markets, such as Asia Pacific and Latin America, where growth of the biotechnology and biopharmaceutical industry is expected to increase significantly.

The High Content Screening (HCS) market report starts with an overview of cell analysis instrumentation market. In addition, this section includes FMI’s analysis of the key trends, drivers and restraints from the supply, demand and economy side, which are influencing the High Content Screening (HCS) market. Impact analysis of key growth drivers and restraints, based on the weighted average model is included in the High Content Screening (HCS) Market report to better equip and arm clients with crystal clear decision-making insights.

The global High Content Screening (HCS) market is segmented on the basis of product, application, industry and regions. On the basis of product, the market is segmented as cell imaging and analysis equipment, consumables, software and services. Cell imaging and analysis equipment is further sub-segmented as High Content Screening (HCS) instruments and flow cytometers. Also, High Content Screening (HCS) instruments are categorised into high-end High Content Screening (HCS), mid-end High Content Screening(HCS) and low-end High Content Screening (HCS) instruments. A detailed analysis has been provided for every segment in terms of market size and volume analysis for High Content Screening (HCS) instruments across the globe.

In the next section, FMI covers the High Content Screening (HCS) market performance in terms of application. On the basis of application, the High Content Screening (HCS) market is segmented into primary and secondary screening, target identification and validation, toxicity studies, compound profiling and others. A detailed analysis has been provided for every segment in terms of market size.

Also, FMI provides the High Content Screening (HCS) market analysis of end-use sectors for High Content Screening (HCS). The segmentation includes pharmaceutical and healthcare, biotechnology companies, educational institutions, government organisations and others. A detailed analysis has been provided for every segment in terms of market size.

As highlighted earlier, the High Content Screening (HCS) market is segmented on the basis of product, application, industry and regions. All these segments are included in this section to make the study more comprehensive. The subsequent sections provide detailed analysis on the product type, industry and application of the High Content Screening (HCS) market report. The sections provide detailed analysis covering key trends, absolute dollar opportunity and BPS Analysis.

The next section of the report highlights High Content Screening (HCS) adoption by regions. It provides market outlook for 2015–2025 and sets the forecast within the context of the High Content Screening (HCS) ecosystem, including the new technological developments as well as product offerings in the High Content Screening (HCS) market. This study discusses the key region trends contributing to growth of the High Content Screening (HCS) market globally, as well as analyses the degree at which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East and Africa.

All the above sections, by product, by application, by industry or by regions, evaluate the present scenario and the growth prospects of the High Content Screening (HCS) market for the period 2015 –2025. We have considered 2014 as the base year and provide data for the trailing 12 months.

To calculate the High Content Screening (HCS) market size, we have considered revenue generated by the High Content Screening (HCS) manufacturers. The forecast presented here assesses the total revenue by value across the High Content Screening (HCS) market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the High Content Screening (HCS) market will develop in the future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis, based on supply side, downstream industry demand and economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse on the basis of key parameters such as year-on-year (Y-o-Y) growth to understand the predictability of the market and to identify the right opportunities across the High Content Screening (HCS) market.

As previously highlighted, the High Content Screening (HCS) market is split into a number of segments and sub-segments. All the High Content Screening (HCS) segments in terms of product type, application, industry and regions are analysed in terms of Basis Point Share to understand individual segment’s relative contributions to market growth. This detailed level of information is important for the identification of various key trends of the High Content Screening (HCS) market.

Also, another key feature of this report is the analysis of all key segments and sub-segments in terms of absolute dollar. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective in the High Content Screening (HCS) market.

Furthermore, to understand key growth segments in terms of growth & adoption of high content screening for cell analysis along with preferred application across the globe in the near future, Future Market Insights developed the High Content Screening (HCS) Market Attractiveness Index. The resulting index should help providers identify real market opportunities.

In the final section of the report, High Content Screening (HCS) Competitive landscape is included to provide report audiences with a Dashboard view, based on categories of provider in the value chain, presence in High Content Screening (HCS) product portfolio and key differentiators. Key categories of providers covered in the report are High Content Screening (HCS) manufacturers. This section is primarily designed to provide clients with an objective & detailed comparative assessment of key providers specific to a market segment in the High Content Screening (HCS) value chain and the potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and success in High Content Screening (HCS) marketplace. Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings and recent developments in the High Content Screening (HCS) space. Key competitors covered in terms of manufacturers are Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., GE Healthcare, Olympus Corporation, PerkinElmer Inc., Merck Millipore Corporation, Danaher Corporation (Molecular Devices), Yokogawa Electric Corporation, Sysmex Corporation and Thorlabs Inc.

Table Of Content

1. Research Methodology

2. Assumptions & Acronyms Used

3. Executive Summary

4. Global HCS Market Overview

    4.1. Introduction

         4.1.1. Global HCS Market: Taxonomy

         4.1.2. Global HCS Market: Definition

    4.2. Cell Analysis Instrumentation Market Outlook

         4.2.1. Cell Analysis Instrumentation Market Size & Forecast

    4.3. Global HCS Market Outlook

    4.4. Global HCS Market Value & Y-o-Y Growth Forecast

    4.5. Global HCS Market Volume & Y-o-Y Growth Forecast

    4.6. Global HCS Market Dynamics

         4.6.1. Global HCS Market Drivers

                4.6.1.1. Economic

                4.6.1.2. Demand

                4.6.1.3. Supply

         4.6.2. Global HCS Market: Restraints

5. Global HCS Market Outlook By Product

    5.1. Introduction

    5.2. Global HCS Market Value Share & BPS Analysis By Product

    5.3. Y-o-Y Growth Comparison By Product

    5.4. Cell Imaging & Analysis Instruments

         5.4.1. Global HCS Market Value & Y-o-Y Forecast By Cell Imaging & Analysis Equipment

         5.4.2. Global HCS Market Value Share & BPS Analysis By Cell Imaging & Analysis Equipment

    5.5. Global HCS Market Analysis By Consumables

         5.5.1. Global HCS Market Value Share & BPS Analysis By Consumables

    5.6. Global HCS Market Analysis By Software

         5.6.1. Global HCS Market Value Share & BPS Analysis By Software

    5.7. Global HCS Market Analysis By Services

         5.7.1. Global HCS Market Value Share & BPS Analysis By Services

    5.8. Global HCS Market Attractiveness Analysis By Product

    5.9. Global HCS Market Key Trends By Product

6. Global HCS Market Outlook By Application    

    6.1. Introduction

    6.2. Global HCS Market Value Share & BPS Analysis By Application

    6.3. Y-o-Y Growth Comparison By Application

    6.4. Primary & Secondary Screening

         6.4.1. Market Value & Y-o-Y Forecast

         6.4.2. Total Opportunity

    6.5. Target Identification & Validation

         6.5.1. Market Value & Y-o-Y Forecast

         6.5.2. Total Opportunity

    6.6. Toxicity Studies

         6.6.1. Market Value & Y-o-Y Forecast

         6.6.2. Total Opportunity

    6.7. Compound Profiling

         6.7.1. Market Value & Y-o-Y Forecast

         6.7.2. Total Opportunity

    6.8. Others

         6.8.1. Market Value & Y-o-Y Forecast

         6.8.2. Total Opportunity

    6.9. Global HCS Market Attractiveness Analysis By Application

6.10. Global HCS Market Key Trends By Application

7. Global HCS Market Outlook By Industry

    7.1. Introduction

    7.2. Global HCS Market Value Share & BPS Analysis By Industry

    7.3. Y-o-Y Growth Comparison By Industry

    7.4. Pharmaceutical & Healthcare

         7.4.1. Market Value & Y-o-Y Forecast

         7.4.2. Total Opportunity

    7.5. Biotechnology

         7.5.1. Market Value & Y-o-Y Forecast

         7.5.2. Total Opportunity

    7.6. Educational Institutions

         7.6.1. Market Value & Y-o-Y Forecast

         7.6.2. Total Opportunity

    7.7. Independent Contract Research Organisation

         7.7.1. Market Value & Y-o-Y Forecast

         7.7.2. Total Opportunity

    7.8. Government Organisation

         7.8.1. Market Value & Y-o-Y Forecast

         7.8.2. Total Opportunity

    7.9. Others

         7.9.1. Market Value & Y-o-Y Forecast

         7.9.2. Total Opportunity

    7.10. Global HCS Market Attractiveness Analysis By Industry

    7.11. Global HCS Market Key Trends By Industry

8. Global HCS Market Outlook By Regions

    8.1. Introduction

    8.2. Global HCS Market Value Share and BPS Analysis By Regions

    8.3. North America HCS Market Value & Y-o-Y Growth Forecast

         8.3.1. North America HCS Market Value Share & BPS Analysis By Product

    8.4. Latin America HCS Market Value & Y-o-Y Growth Forecast

         8.4.1. Latin America HCS Market Value Share & BPS Analysis By Product

    8.5. Western Europe HCS Market Value & Y-o-Y Growth Forecast

         8.5.1. Western Europe HCS Market Value Share & BPS Analysis By Product

    8.6. Eastern Europe HCS Market Value & Y-o-Y Growth Forecast

         8.6.1. Eastern Europe HCS Market Value Share & BPS Analysis By Product

    8.7. Asia Pacific Excluding Japan (APEJ) HCS Market Value & Y-o-Y Growth Forecast

         8.7.1. APEJ HCS Market Value Share & BPS Analysis By Product

    8.8. Japan HCS Market Value & Y-o-Y Growth Forecast

         8.8.1. Japan HCS Market Value Share & BPS Analysis By Product

    8.9. MEA HCS Market Value & Y-o-Y Growth Forecast

    8.10. MEA HCS Market Value Share & BPS Analysis By Product

    8.11. Global HCS Market Key Trends By Regions

9. Competitive Landscape

    9.1. Company Dashboard

    9.2. Company Profiles

         9.2.1. Becton, Dickinson and Company

         9.2.2. Thermo Fisher Scientific Inc.

         9.2.3. GE Healthcare

         9.2.4. Olympus Corporation

         9.2.5. PerkinElmer Inc.

         9.2.6. Merck Millipore Corporation

         9.2.7. Danaher Corporation (Molecular Devices)

         9.2.8. Yokogawa Electric Corporation

         9.2.9. Sysmex Corporation

         9.2.10. Thorlabs, Inc.

10. Key Comments by Industry Experts

List of Tables

Table 1: Global HCS Market Value and Volume Forecast By Cell imaging and Analysis Equipment, 2012–2025 (US$ Mn)

Table 2: Global HCS Market Value Forecast By Product, 2012–2025 (US$ Mn)

Table 3: Global HCS Market Value Forecast By Application, 2012–2025 (US$ Mn)

Table 4: Global HCS Market Value Forecast By Industry, 2012–2025 (US$ Mn)

List of Figures

Figure 1: Global Cell Analysis Instrumentation Market Size & Y-o-Y Growth Forecast, 2015–2025

Figure 2: Global Cell Analysis Instrumentation Market Size Forecast, 2015, 2020 & 2025

Figure 3: Global HCS Market Size & Y-o-Y Growth Forecast, 2012–2025

Figure 4: Global HCS Market Volume & Y-o-Y Growth Forecast, 2012–2025

Figure 5: Global HCS Market Value Absolute $ Opportunity, 2013–2020

Figure 6: Global HCS Market Size and Y-o-Y Growth Forecast, 2013–2025

Figure 7: Global HCS Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025 (%)

Figure 8: Global HCS Market Y-o-Y Growth Comparison By Product, 2015 & 2020 (%)

Figure 9: Global HCS Market Value & Y-o-Y Growth Forecast By Cell Imaging & Analysis Equipment, 2012–2025

Figure 10: Global HCS Market Value Absolute $ Opportunity By Cell Imaging & Analysis Equipment, 2013–2020

Figure 11: Global HCS Market Value Share & BPS Analysis By Cell Imaging & Analysis  Equipment, 2015, 2020 & 2025 (%)

Figure 12: Global HCS Market Value & Y-o-Y Growth Forecast By Consumables, 2012–2025

Figure 13: Global HCS Market Value Absolute $ Opportunity By Consumables, 2013–2025

Figure 14: Global HCS Market Value Share & BPS Analysis By Consumables, 2015, 2020 & 2025 (%)

Figure 15: Global HCS Market Value & Y-o-Y Growth Forecast By Software, 2012–2025

Figure 16: Global HCS Market Value Absolute $ Opportunity By Software, 2013–2020

Figure 17: Global HCS Market Value & Y-o-Y Growth Forecast By Services, 2012–2025

Figure 18: Global HCS Market Value Absolute $ Opportunity By Services, 2013–2020

Figure 19: Global HCS Market Attractiveness Analysis By Product, 2015–2025

Figure 20: Global HCS Market Attractiveness Analysis By Product Sub-Segment, 2015–2025

Figure 21: Global HCS Market Value Share & BPS Analysis By Application, 2015, 2020 & 2025 (%)

Figure 22: Global HCS Market Y-o-Y Growth Comparison By Application, 2015 & 2020 (%)

Figure 23: Global HCS Market Value & Y-o-Y Growth Forecast By Primary and Secondary Screening, 2012–2025

Figure 24: Global HCS Market Value Absolute $ Opportunity By Primary and Secondary Screening, 2013–2020

Figure 25: Global HCS Market Value & Y-o-Y Growth Forecast By Target Identification and Validation, 2012–2025

Figure 26: Global HCS Market Value Absolute $ Opportunity By Target Identification and Validation, 2013–2020

Figure 27: Global HCS Market Value & Y-o-Y Growth Forecast By Toxicity Studies, 2012–2025

Figure 28: Global HCS Market Value Absolute $ Opportunity By Toxicity Studies, 2013–2020

Figure 29: Global HCS Market Value & Y-o-Y Growth Forecast By Compound Profiling, 2012–2025

Figure 30: Global HCS Market Value Absolute $ Opportunity By Compound Profiling, 2013–2020

Figure 31: Global HCS Market Value & Y-o-Y Growth Forecast By Other Applications, 2012–2025

Figure 32: Global HCS Market Value Absolute $ Opportunity By Other Applications, 2013–2020

Figure 33: Global HCS Market Attractiveness Analysis By Application, 2015–2025

Figure 34: Global HCS Market Value Share & BPS Analysis By Industry, 2015, 2020 & 2025 (%)

Figure 35: Global HCS Market Y-o-Y Growth Comparison By Industry, 2015 & 2020 (%)

Figure 36: Global HCS Market Value & Y-o-Y Growth Forecast By Pharmaceutical & Healthcare, 2012–2025

Figure 37: Global HCS Market Value Absolute $ Opportunity By Pharmaceutical & Healthcare, 2013–2020

Figure 38: Global HCS Market Value & Y-o-Y Growth Forecast By Biotechnology, 2012–2025

Figure 39: Global HCS Market Value Absolute $ Opportunity By Biotechnology, 2013–2020

Figure 40: Global HCS Market Value & Y-o-Y Growth Forecast By Educational Institutions, 2012–2025

Figure 41: Global HCS Market Value Absolute $ Opportunity By Educational Institutions, 2013–2020

Figure 42: Global HCS Market Value & Y-o-Y Growth Forecast By Independent CRO, 2012–2025

Figure 43: Global HCS Market Value Absolute $ Opportunity By Independent CRO, 2013–2020

Figure 44: Global HCS Market Value & Y-o-Y Growth Forecast By Government Organisations, 2012–2025

Figure 45: Global HCS Market Value Absolute $ Opportunity By Government Organisations, 2013–2020

Figure 46: Global HCS Market Value & Y-o-Y Growth Forecast By Others, 2012–2025

Figure 47: Global HCS Market Value Absolute $ Opportunity By Others, 2013–2020

Figure 48: Global HCS Market Attractiveness Analysis By Industry, 2015–2025

Figure 49: Global HCS Market Value Share & BPS Analysis By Regions, 2015, 2020 & 2025 (%)

Figure 50: North America HCS Market Value & Y-o-Y Growth Forecast, 2012–2025

Figure 51: North America HCS Market Absolute $ Opportunity, 2013–2020

Figure 52 shows North America HCS market value share and BPS analysis by product for 2015, 2020 &2025

Figure 52: North America HCS Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025 (%)

Figure 52: North America HCS Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025 (%)

Figure 53: Latin America HCS Market Value & Y-o-Y Growth Forecast, 2012–2025

Figure 54: Latin America HCS Market Absolute $ Opportunity, 2013–2020

Figure 55: Latin America HCS Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025 (%)

Figure 56: Western Europe HCS Market Value & Y-o-Y Growth Forecast, 2012–2025

Figure 57: Western Europe HCS Market Absolute $ Opportunity, 2013–2020

Figure 58: Western Europe HCS Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025 (%)

Figure 59: Eastern Europe HCS Market Value & Y-o-Y Growth Forecast, 2012–2025

Figure 60: Eastern Europe HCS Market Absolute $ Opportunity, 2013–2020

Figure 61: Eastern Europe HCS Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025 (%)

Figure 62: APEJ HCS Market Value & Y-o-Y Growth Forecast, 2012–2025

Figure 63: APEJ HCS Market Absolute $ Opportunity, 2013–2020

Figure 64: APEJ HCS Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025 (%)

Figure 65: Japan HCS Market Value & Y-o-Y Growth Forecast, 2012–2025

Figure 66: Japan HCS Market Absolute $ Opportunity, 2013–2020

Figure 67: Japan HCS Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025 (%)

Figure 68: MEA HCS Market Value & Y-o-Y Growth Forecast, 2012–2025

Figure 69: MEA HCS Market Absolute $ Opportunity, 2013–2020

Figure 70: MEA HCS Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025 (%)